Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

Delayed Quote. Delayed  - 01/20 10:00:55 pm
144.77 USD   +0.42%
01/20 CIGNA : Anthem Extends End Date of Cigna Deal
01/19 CIGNA CORPORATI : CI) Files An 8-K Other Events
01/19 ANTHEM, INC. (N : ANTX) Files An 8-K Other Events
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

CIGNA Corporation : Cigna CEO David Cordani and Wounded Veteran and Achilles Athlete Matias Ferreira Complete the Walt Disney World® Half Marathon

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/07/2012 | 09:15pm CET

A photo of Cigna CEO David Cordani and LCpl Matias Ferreira at the Walt Disney World® Marathon Weekend is available on Business Wire's Website and AP PhotoExpress.

Cigna CEO David Cordani and LCpl Matias Ferreira (right), show the medals they won today by completi ...

Cigna CEO David Cordani and LCpl Matias Ferreira (right), show the medals they won today by completing the half marathon together at the Walt Disney World(R) Marathon Weekend presented by Cigna. Ferreira, 22, originally from Atlanta and now living in Rockville, Maryland, is a U.S. Marine who lost both legs while serving in Afghanistan in 2011. Cordani served as a running guide to Ferreira, who is a member of the Achilles International Freedom Team. Achilles is an organization that helps people with disabilities, including wounded U.S. Armed Forces veterans, compete in mainstream athletic events. Cigna sponsored several members of the Achilles team at today's half marathon. (Photo: Business Wire)

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50125946&lang=en

Cigna
Gloria Barone, 609-284-7605


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
01/20 CIGNA : Anthem Extends End Date of Cigna Deal
01/19 CIGNA : and Scripps Health Form Alliance to Deliver Innovative Health Plans in S..
01/19 CIGNA CORPORATION (NYSE : CI) Files An 8-K Other Events
01/19 CIGNA CORP : Other Events (form 8-K)
01/19 ANTHEM, INC. (NYSE : ANTX) Files An 8-K Other Events
01/17 CIGNA : CMC Passed PCI DSS Compliance Certification
01/13 CIGNA : and Scripps Health Form Alliance to Deliver Innovative Health Plans in S..
01/13 CIGNA CORPORATION : Blog Coverage Expensive EpiPen Proves Costly for Mylan as Ci..
01/13 CIGNA : Launches Fingerprint Access Feature to Help Customers Manage Their Healt..
01/12DJCigna Drops Coverage of Mylan's EpiPen for Cheaper Generic -- Update
More news
Sector news : Managed Healthcare - NEC
01/19DJANTHEM : Ends Preauthorization for Medication to Treat Opioid Addiction -- Updat..
01/19DJANTHEM : Ends Preauthorization for Medication to Treat Opioid Addiction
01/18DJLower Oil Prices Drag on Energy Stocks
01/18DJMore Women Are Winning CEO Job -- WSJ
01/18DJUNITEDHEALTH : Says ACA Drag Is Easing -- WSJ
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
01/20 Health insurers may benefit from repeal of ACA says TheStreet's Gamm
01/19 New Deal Talk As Tesla Hits Ludicrous Speed
01/19 Cigna has plenty of ammo for acquisitions if Anthem deal blocked
01/19 District court expected to block Cigna/Anthem merger
01/19 Cigna to "evaluate options" after court ruling on Anthem merger
Advertisement
Financials ($)
Sales 2016 39 599 M
EBIT 2016 3 368 M
Net income 2016 1 942 M
Debt 2016 1 292 M
Yield 2016 0,02%
P/E ratio 2016 19,38
P/E ratio 2017 15,85
EV / Sales 2016 0,97x
EV / Sales 2017 0,92x
Capitalization 37 168 M
More Financials
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 156 $
Spread / Average Target 8,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Mark Marsters Senior Vice President-Group Operations
Thomas A. McCarthy Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION8.53%37 168
UNITEDHEALTH GROUP INC-0.86%151 015
AETNA INC-1.19%42 996
ANTHEM INC4.77%39 681
HUMANA INC-1.72%29 899
CENTENE CORP12.03%10 819
More Results